Drug
AGMB-129
AGMB-129 is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
3
75%
Ph phase_2
1
25%
Phase Distribution
3
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
Phase 2Efficacy & side effects
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (75.0%)
Phase 21 (25.0%)
Trials by Status
completed375%
active_not_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruitingphase_2
STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease
NCT05843578
completedphase_1
A Multiple Ascending Dose Study With AGMB-129 in Healthy Participants
NCT07118878
completedphase_1
Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy Participants
NCT05937386
completedphase_1
Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants
NCT06397508
Clinical Trials (4)
Showing 4 of 4 trials
NCT05843578Phase 2
STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease
NCT07118878Phase 1
A Multiple Ascending Dose Study With AGMB-129 in Healthy Participants
NCT05937386Phase 1
Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy Participants
NCT06397508Phase 1
Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4